| UniProt ID | LYSM2_HUMAN | |
|---|---|---|
| UniProt AC | Q8IV50 | |
| Protein Name | LysM and putative peptidoglycan-binding domain-containing protein 2 | |
| Gene Name | LYSMD2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 215 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MADSSPALSLREGGPRAPRPSAPSPPPRSRSGSESEEAELSLSLARTKTRSYGSTASVRAPLGAGVIERHVEHRVRAGDTLQGIALKYGVTMEQIKRANKLFTNDCIFLKKTLNIPVISEKPLLFNGLNSIDSPENETADNSFSQEEEPVVAGEDLPPPSPQESDVQPVQPEEVSARDFLQRLDLQIKLSTQAAKKLKEESRDEESPYATSLYHS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MADSSPALS ------CCCCCCCCC | 25.95 | 22814378 | |
| 4 | Phosphorylation | ----MADSSPALSLR ----CCCCCCCCCCC | 28.78 | 29255136 | |
| 5 | Phosphorylation | ---MADSSPALSLRE ---CCCCCCCCCCCC | 18.10 | 23401153 | |
| 9 | Phosphorylation | ADSSPALSLREGGPR CCCCCCCCCCCCCCC | 27.73 | 22199227 | |
| 21 | Phosphorylation | GPRAPRPSAPSPPPR CCCCCCCCCCCCCCC | 54.83 | 30266825 | |
| 24 | Phosphorylation | APRPSAPSPPPRSRS CCCCCCCCCCCCCCC | 50.16 | 29255136 | |
| 29 | Phosphorylation | APSPPPRSRSGSESE CCCCCCCCCCCCHHH | 36.25 | 29255136 | |
| 31 | Phosphorylation | SPPPRSRSGSESEEA CCCCCCCCCCHHHHH | 48.17 | 30278072 | |
| 33 | Phosphorylation | PPRSRSGSESEEAEL CCCCCCCCHHHHHHH | 38.91 | 30278072 | |
| 35 | Phosphorylation | RSRSGSESEEAELSL CCCCCCHHHHHHHHH | 42.29 | 25159151 | |
| 41 | Phosphorylation | ESEEAELSLSLARTK HHHHHHHHHHHHHHC | 13.86 | 30301811 | |
| 43 | Phosphorylation | EEAELSLSLARTKTR HHHHHHHHHHHHCCC | 19.33 | 30301811 | |
| 49 | Phosphorylation | LSLARTKTRSYGSTA HHHHHHCCCCCCCCE | 25.00 | 27251275 | |
| 51 | Phosphorylation | LARTKTRSYGSTASV HHHHCCCCCCCCEEE | 38.79 | 28555341 | |
| 52 | Phosphorylation | ARTKTRSYGSTASVR HHHCCCCCCCCEEEE | 16.29 | - | |
| 54 | Phosphorylation | TKTRSYGSTASVRAP HCCCCCCCCEEEECC | 16.74 | 27251275 | |
| 55 | Phosphorylation | KTRSYGSTASVRAPL CCCCCCCCEEEECCC | 20.70 | 29214152 | |
| 57 | Phosphorylation | RSYGSTASVRAPLGA CCCCCCEEEECCCCC | 16.54 | 23401153 | |
| 103 | Phosphorylation | KRANKLFTNDCIFLK HHHHHHCCCCEEEEE | 40.35 | 25599653 | |
| 110 | Ubiquitination | TNDCIFLKKTLNIPV CCCEEEEECCCCCCC | 32.72 | - | |
| 110 | Acetylation | TNDCIFLKKTLNIPV CCCEEEEECCCCCCC | 32.72 | 27452117 | |
| 195 | Acetylation | KLSTQAAKKLKEESR HHHHHHHHHHHHHHC | 62.75 | 25953088 | |
| 201 | Phosphorylation | AKKLKEESRDEESPY HHHHHHHHCCCCCCC | 46.23 | 22199227 | |
| 206 | Phosphorylation | EESRDEESPYATSLY HHHCCCCCCCHHHCC | 22.59 | 28796482 | |
| 208 | Phosphorylation | SRDEESPYATSLYHS HCCCCCCCHHHCCCC | 31.61 | 25159151 | |
| 210 | Phosphorylation | DEESPYATSLYHS-- CCCCCCHHHCCCC-- | 17.27 | 28796482 | |
| 211 | Phosphorylation | EESPYATSLYHS--- CCCCCHHHCCCC--- | 20.82 | 28796482 | |
| 213 | Phosphorylation | SPYATSLYHS----- CCCHHHCCCC----- | 10.36 | 28796482 | |
| 215 | Phosphorylation | YATSLYHS------- CHHHCCCC------- | 28.49 | 28796482 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LYSM2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LYSM2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LYSM2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of LYSM2_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-208 AND TYR-213, ANDMASS SPECTROMETRY. | |